Skip to main content
. 2020 Nov;8(21):1349. doi: 10.21037/atm-20-2493

Table 2. Comparison of baseline and clinical characteristics of subjects according to the H-FABP levels (ng/mL).

Variables Quartile 1 (<1.50) Quartile 2 (1.50–2.20) Quartile 3 (2.21–3.00) Quartile 4 (>3.00) P value
Baseline characteristics
   Patients 1,134 1,091 1,147 998
   Age (years) 54.2±9.0 57.2±8.9 59.0±9.3 62.9±9.6 <0.001
   Male 798 (70.4) 781 (71.6) 824 (71.8) 684 (68.5) 0.329
   BMI (kg/m2) 25.83±2.95 25.89±3.15 25.88±3.09 26.12±3.39 0.166
   Hypertension 703 (62.0) 678 (62.1) 752 (65.6) 733 (73.4) <0.001
   Dyslipidemia 1,016 (89.6) 1,003 (91.9) 1,035 (90.2) 891 (89.3) 0.161
   Diabetes 602 (53.1) 599 (54.9) 651 (56.8) 549 (55.0) 0.376
   Current Smokers 337 (29.7) 374 (34.3) 357 (31.1) 277 (27.8) 0.011
   Peripheral vascular disease 10 (0.9) 15 (1.4) 14 (1.2) 20 (1.8) 0.156
   Cerebrovascular disease 24 (2.1) 35 (3.2) 36 (3.1) 41 (4.1) 0.070
   Family history of CAD 172 (15.2) 179 (16.4) 154 (13.4) 106 (10.6) 0.001
Laboratory data
   Triglyceride (mmol/L) 1.85±1.43 1.78±1.10 1.79±1.12 1.76±1.26 0.403
   TC (mmol/L) 4.14±1.23 4.15±1.12 4.14±1.20 4.12±1.12 0.923
   LDL (mmol/L) 2.52±1.06 2.55±1.07 2.49±0.91 2.47±0.94 0.231
   HbA1c (%) 6.39±1.17 6.47±1.23 6.53±1.17 6.78±1.31 <0.001
   Troponin I (ng/mL) 0.003 (0.001–0.007) 0.004 (0.002–0.008) 0.004 (0.002–0.010) 0.006 (0.002–0.013) <0.001
   Creatinine (μmol/L) 73.75±14.38 75.40±13.59 77.16±15.30 85.65±22.34 <0.001
Treatments in hospital
   Aspirin 1,099 (96.9) 1,068 (96.9) 1,106 (96.4) 969 (97.1) 0.224
   β-Blokers 895 (78.9) 847 (77.6) 911 (79.4) 764 (76.6) 0.369
   Lipid-lowering medication 1041 (91.8) 1010 (92.6) 1065 (92.9) 942 (94.4) 0.134
   ACEI or ARB 478 (42.1) 481 (44.1) 537 (46.8) 528 (52.9) <0.001
Multi-vessel disease ≥3 412 (36.2) 436 (40.1) 472 (41.3) 430 (43.1) 0.012
Gensini score 31.9±30.3 33.8±31.2 34.7±30.8 37.9±35.7 <0.001
Cardiovascular events 66 (5.8) 81 (7.4) 93 (8.3) 113 (11.3) <0.001

Values are expressed as the mean ± SD, the median with interquartile range or n (%). CAD, coronary artery disease; BMI, Body mass index; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycated hemoglobin; H-FABP, heart-fatty acid binding protein; TnI, troponin I; ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blocker.